Related references
Note: Only part of the references are listed.A proposal for pathologic processing of breast implant capsules in patients with suspected breast implant anaplastic large cell lymphoma
Kirill A. Lyapichev et al.
MODERN PATHOLOGY (2020)
Best Practices Guideline for the Pathologic Diagnosis of Breast Implant-Associated Anaplastic Large-Cell Lymphoma
Elaine S. Jaffe et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Targetability of STAT3-JAK2 fusions: implications for T-cell lymphoproliferative disorders of the gastrointestinal tract
Guangzhen Hu et al.
LEUKEMIA (2020)
Breast implant-associated anaplastic large cell lymphoma: a review
Andres E. Quesada et al.
MODERN PATHOLOGY (2019)
2019 NCCN Consensus Guidelines on the Diagnosis and Treatment of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)
Mark W. Clemens et al.
AESTHETIC SURGERY JOURNAL (2019)
Targeted next generation sequencing of breast implant-associated anaplastic large cell lymphoma reveals mutations in JAK/STAT signalling pathway genes, TP53 and DNMT3A
Arianna Di Napoli et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
Clinicopathologic Features and Prognostic Impact of Lymph Node Involvement in Patients With Breast Implant-associated Anaplastic Large Cell Lymphoma
Maria C. Ferrufino-Schmidt et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2018)
Recurrent STAT3-JAK2 fusions in indolent T-cell lymphoproliferative disorder of the gastrointestinal tract
Ayush Sharma et al.
BLOOD (2018)
Genetic subtyping of breast implant-associated anaplastic large cell lymphoma
Naoki Oishi et al.
BLOOD (2018)
Dual JAK1 and STAT3 mutations in a breast implant-associated anaplastic large cell lymphoma
Audrey Letourneau et al.
VIRCHOWS ARCHIV (2018)
Fusion of the genes ataxin 2 like, ATXN2L, and Janus kinase 2, JAK2, in cutaneous CD4 positive T-cell lymphoma
Ioannis Panagopoulos et al.
ONCOTARGET (2017)
Breast implant-associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomes
C. Laurent et al.
ANNALS OF ONCOLOGY (2016)
Whole exome sequencing reveals activating JAK1 and STAT3 mutations in breast implant-associated anaplastic large cell lymphoma anaplastic large cell lymphoma
Piers Blombery et al.
HAEMATOLOGICA (2016)
Complete Surgical Excision Is Essential for the Management of Patients With Breast Implant-Associated Anaplastic Large-Cell Lymphoma
Mark W. Clemens et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Distinct genetic evolution patterns of relapsing diffuse large B-cell lymphoma revealed by genome-wide copy number aberration and targeted sequencing analysis
D. Juskevicius et al.
LEUKEMIA (2016)
FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing
Ronglai Shen et al.
NUCLEIC ACIDS RESEARCH (2016)
Th17 cytokine differentiation and loss of plasticity after SOCS1 inactivation in a cutaneous T-cell lymphoma
Stefan Ehrentraut et al.
ONCOTARGET (2016)
Whole exome sequencing reveals activating JAK1 and STAT3 mutations in breast implant-associated anaplastic large cell lymphoma anaplastic large cell lymphoma
Piers Blombery et al.
HAEMATOLOGICA (2016)
Convergent Mutations and Kinase Fusions Lead to Oncogenic STAT3 Activation in Anaplastic Large Cell Lymphoma
Ramona Crescenzo et al.
CANCER CELL (2015)
ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes
Edgardo R. Parrilla Castellar et al.
BLOOD (2014)
Breast Implant-Associated Anaplastic Large-Cell Lymphoma: Long-Term Follow-Up of 60 Patients
Roberto N. Miranda et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Molecular Pathways: JAK/STAT Pathway: Mutations, Inhibitors, and Resistance
Alfonso Quintas-Cardama et al.
CLINICAL CANCER RESEARCH (2013)
t(8;9)(p22;p24)/PCM1-JAK2 Activates SOCS2 and SOCS3 via STAT5
Stefan Ehrentraut et al.
PLOS ONE (2013)
Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas
George Vasmatzis et al.
BLOOD (2012)
Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing
Andrew L. Feldman et al.
BLOOD (2011)
Inactivating SOCS1 mutations are caused by aberrant somatic hypermutation and restricted to a subset of B-cell lymphoma entities
Anja Mottok et al.
BLOOD (2009)
The saga of JAK2 mutations and translocations in hematologic disorders: pathogenesis, diagnostic and therapeutic prospects, and revised World Health Organization diagnostic criteria for myeloproliferative neoplasms
Cristina A. Smith et al.
HUMAN PATHOLOGY (2008)
Mutations of the tumor suppressor gene SOCS-1 in classical Hodgkin lymphoma are frequent and associated with nuclear phospho-STAT5 accumulation
MA Weniger et al.
ONCOGENE (2006)
A t(8;9) translocation with PCM1-JAK2 fusion in a patient with T-cell lymphoma
J Adélaïde et al.
LEUKEMIA (2006)
Share Paper
